Atlas Trials

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

Clinical trial NCT03598348 · UNKNOWN

Trial details

NCT number
NCT03598348
Sponsor
Huazhong University of Science and Technology
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2018-01-16
Primary completion
2020-01-16
Enrollment
288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.